SCSuvo Chatterjee

Suvo Chatterjee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Suvo Chatterjee has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ReMeDy : A Flexible Statistical Framework for Region‐Based Detection of DNA Methylation Dysregulation

    by Suvo Chatterjee, Siddhant Meshram, Ganesan Arunkumar, Fasil Tekola‐Ayele, Arindam Fadikar

    Region‐based epigenome‐wide association studies have demonstrated improved statistical power and biological interpretability compared with probe‐wise analyses of DNA methylation data. However, most existing region‐based methods characterize methylation dysregulation primarily through changes in mean methylation levels associated with a phenotype of interest. Substantial evidence indicates that phenotype‐associated methylation alterations may also manifest through changes in methylation variability or through joint shifts in mean and variability. Despite this, no existing statistical framework jointly models mean–variance methylation changes in a region‐based manner. We propose ReMeDy, a flexible statistical framework that uses a hierarchical likelihood approach within a generalized linear model setting to identify differentially methylated regions, variably methylated regions, and regions exhibiting joint differential and variable methylation at a genome‐wide scale. Unlike existing models, ReMeDy operates directly on biologically defined co‐methylated regions, allowing it to naturally capture spatial correlation inherent in DNA methylation array data, while avoiding reliance on heuristic, user‐defined tuning parameters such as smoothing spans and kernel bandwidths that can substantially influence results and introduce subjectivity. Through extensive simulation studies and comprehensive benchmarking against popular models, we demonstrate that ReMeDy maintains false discovery and Type‐I error rates at nominal levels while achieving consistently higher statistical power across a wide range of realistic scenarios. Application to population‐level DNA methylation data further shows that ReMeDy identifies biologically meaningful regions and pathways implicated in complex human diseases that are not captured by conventional mean‐based analyses alone. ReMeDy is implemented as an open‐source R package and is freely available at https://github.com/SChatLab/ReMeDy .

  • Open Access

    ReMeDy: A Flexible Statistical Framework For Region-based Detection of DNA Methylation Dysregulation

    by Suvo Chatterjee, Siddhant Meshram, Arunkumar Ganesan, Fasil Tekola-Ayele, Arindam Fadikar

    Region-based epigenome-wide association studies have demonstrated improved statistical power and biological interpretability compared with probe-wise analyses of DNA methylation data. However, most existing region-based methods characterize methylation dysregulation primarily through changes in mean methylation levels associated with a phenotype of interest. Substantial evidence indicates that phenotype-associated methylation alterations may also manifest through changes in methylation variability or through joint shifts in mean and variability. Despite this, no existing statistical framework jointly models mean-variance methylation changes in a region-based manner. We propose ReMeDy, a flexible statistical framework that uses a hierarchical likelihood approach within a generalized linear model setting to identify differentially methylated regions, variably methylated regions, and regions exhibiting joint differential and variable methylation at a genome-wide scale. Unlike existing models, ReMeDy operates directly on biologically defined co-methylated regions, allowing it to naturally capture spatial correlation inherent in DNA methylation array data, while avoiding reliance on heuristic, user-defined tuning parameters such as smoothing spans and kernel bandwidths that can substantially influence results and introduce subjectivity. Through extensive simulation studies and comprehensive benchmarking against popular models, we demonstrate that ReMeDy maintains false discovery and type-I error rates at nominal levels while achieving consistently higher statistical power across a wide range of realistic scenarios. Application to population-level DNA methylation data further shows that ReMeDy identifies biologically meaningful regions and pathways implicated in complex human diseases that are not captured by conventional mean-based analyses alone. ReMeDy is implemented as an open-source R package and is freely available at https://github.com/SChatLab/ReMeDy.

  • Open Access

    A spatially-aware unsupervised pipeline to identify co-methylation regions in DNA methylation data

    by Siddhant Meshram, Arindam Fadikar, Ganesan Arunkumar, Suvo Chatterjee

    DNA methylation (DNAm) plays a central role in modern epigenetic research; however, the high dimensionality of DNAm data comprising hundreds of thousands of spatially ordered probes continues to present major analytical challenges. The multiple testing burden in these data introduces redundancy and reduces statistical power, contributing to the limited reproducibility often observed in association studies. Moreover, DNAm probes frequently exhibit correlated methylation patterns with neighboring sites, reflecting underlying biological co-regulation and spatial dependence along the genome. Ignoring these spatial correlations can bias parameter and standard error estimates, inflate type I error rates, and obscure biologically meaningful effects. Existing methods for detecting methylation co-regulation and reducing DNAm data dimensions, typically rely on fixed distance or correlation thresholds and arbitrary hyperparameter settings that lack data adaptivity. In this study, we introduce SACOMA (Spatially-Aware Clustering for Co-Methylation Analysis), a flexible, data-driven, and unsupervised framework designed to identify co-methylated regions which are genomic regions where adjacent sites show correlated methylation levels. SACOMA employs spatially constrained hierarchical clustering to group neighboring DNAm sites based on both spatial proximity and methylation similarity. A tunable, data-adaptive mixing parameter allows SACOMA to avoid rigid assumptions and remain robust to hyperparameter choices. Although developed for DNAm array data, SACOMA provides a generalizable framework applicable to any data exhibiting spatial dependence, enabling the identification of spatially correlated features across diverse domains. Through extensive simulations, SACOMA demonstrated superior sensitivity while maintaining effective false-positive control compared to existing methods. In population-level DNAm data analyses, SACOMA successfully identified biologically relevant co-regulated methylation regions with functional roles. Overall, SACOMA reduces the multiple-testing burden and enhances both the discovery and specificity of statistical associations, leading to improved reproducibility and more reliable biological inference.


  • Association of placental weight and placental-fetal weight ratio with DNA methylation in placenta

    by Suvo Chatterjee, Jing Wu, Marion Ouidir, Katherine L. Grantz, Fasil Tekola-Ayele

    To investigate the association between placental methylation and placenta weight (PW) and placental-fetal weight ratio (PFR), which are markers of placental function linked to adverse pregnancy outcomes and risk for diseases in later life. We examined the association between placental epigenome-wide methylation and PW and PFR at birth (n = 301). Further tests assessed whether methylation levels of the cytosine-guanine sites (CpGs) linked to PW and PFR are associated with placental expression of nearby genes. At a 5% false discovery rate (FDR), methylation at 27 CpGs was associated with PW, of which two CpGs were also associated with PFR. Methylation at four of the 27 CpGs was associated with placental expression of nearby genes including LEPR, RPS6KA1, and COX5A which have known roles in early development, cellular growth, and oxidative stress. The identified CpGs overlap with previously reported methylation sites associated with perinatal and adult health outcomes such as preeclampsia, preterm delivery, obesity, and type 2 diabetes. The findings reveal epigenetic underpinnings of placental development and functional efficiency, and suggest their potential roles in mediating fetal development and late-onset diseases.


  • Open Access

    Repurposing without Reinventing the Wheel - Ensemble Models for Differential Analysis

    by Suvo Chatterjee, Erina Paul, Ziyu Liu, Jialin Gao, Piyali Basak, Arinjita Bhattacharyya, Chitrak Banerjee, Himel Mallick

    Inspired by ensemble models in machine learning, we propose a general framework for aggregating multiple distinct base models to enhance the power of published differential association analysis (DAA) methods. We demonstrate this approach by augmenting popular DAA models with one or more biologically motivated alternatives. This creates an ensemble that bypasses the challenge of selecting an optimal model and instead combines the strengths of complementary statistical models to achieve superior performance. Our proposed ensemble learning approach is platform-agnostic and can augment any existing DAA method, providing a general and flexible framework for various downstream modeling tasks across domains and data types. We performed extensive benchmarking across both simulated and experimental datasets spanning single-cell gene expression, bulk transcriptomics, and microbiome metagenomics, where the ensemble strategy vastly outperformed non-ensemble methods, identified more differential patterns than the competing methods, and displayed good control of false positive and false discovery rates across diversified scenarios. In addition to highlighting a substantial performance boost for state-of-the-art DAA methods, this work has practical implications for mitigating the so-called reproducibility crisis in omics data science. An open-source R package implementing the ensemble strategy is publicly available at https://github.com/himelmallick/DAssemble .


  • Open Access

    Group Heteroscedasticity - A Silent Saboteur of Power and False Discovery in RNA-Seq Differential Expression

    by Suvo Chatterjee, Arindam Fadikar, Vrushab Hanumesh, Siddhant Sunil Meshram, Roger S Zoh, Siyuan Ma, Ganesan Arunkumar, Himel Mallick

    Despite the availability of several high-profile, state-of-the-art methods, analyzing bulk RNA-Seq data continues to face significant challenges. Evidence from recent studies has highlighted that popular differential expression (DE) tools, such as edgeR and DESeq2, are susceptible to an alarmingly high false discovery rate (FDR). These studies suggest that the FDR inflation observed in these models could be attributed to issues such as violations of parametric assumptions or an inability to effectively handle outliers in the data. Here, we argue that group heteroscedasticity can also contribute to this elevated FDR, a phenomenon largely overlooked by the research community. We introduce a novel statistical model, Robseq, designed for effective per-feature modeling in differential analysis, particularly when the assumption of group homoscedasticity is unmet. Robseq utilizes well-established statistical machinery from the robust statistics literature, including M-estimators to robustly estimate gene expression level changes and Huber-Cameron variance estimators to calculate robust standard errors in heteroscedastic settings. Additionally, it incorporates a degrees of freedom adjustment for the Welch t-statistic, based on Bell-McCaffrey’s recommendation, for inferential purposes, effectively addressing the problem of FDR inflation in RNA-Seq differential expression. Through detailed simulations and comprehensive benchmarking, we show that Robseq successfully maintains the false discovery and type-I error rates at nominal levels while retaining high statistical power compared to well-known DE methods. Analysis of population-level RNA-Seq data further demonstrates that Robseq is capable of identifying biologically significant signals and pathways implicated in complex human diseases that otherwise cannot be revealed by published methods. The implementation of Robseq is publicly available as an R package at https://github.com/schatterjee30/Robseq .


  • Bayesian Functional Data Analysis Over Dependent Regions and Its Application for Identification of Differentially Methylated Regions

    by Suvo Chatterjee, Shrabanti Chowdhury, Duchwan Ryu, Sanjib Basu

    We consider a Bayesian functional data analysis for observations measured as extremely long sequences. Splitting the sequence into several small windows with manageable lengths, the windows may not be independent especially when they are neighboring each other. We propose to utilize Bayesian smoothing splines to estimate individual functional patterns within each window and to establish transition models for parameters involved in each window to address the dependence structure between windows. The functional difference of groups of individuals at each window can be evaluated by the Bayes factor based on Markov Chain Monte Carlo samples in the analysis. In this paper, we examine the proposed method through simulation studies and apply it to identify differentially methylated genetic regions in TCGA lung adenocarcinoma data.